Evofem Biosciences, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Evofem Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Evofem Biosciences, Inc. Return On Equity for the quarter ending June 30, 2024 was -92 %, a 14.3% increase year-over-year.
  • Evofem Biosciences, Inc. annual Return On Equity for 2023 was -90.2 %, a 245% decline from 2022.
  • Evofem Biosciences, Inc. annual Return On Equity for 2022 was 62.1 %, a 87.3% decline from 2021.
  • Evofem Biosciences, Inc. annual Return On Equity for 2021 was 489 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -90.2 -152 -245% Jan 1, 2023 Dec 31, 2023
2022 62.1 -427 -87.3% Jan 1, 2022 Dec 31, 2022
2021 489 +1K Jan 1, 2021 Dec 31, 2021
2020 -512 +174 +25.3% Jan 1, 2020 Dec 31, 2020
2019 -686 -1.77K -163% Jan 1, 2019 Dec 31, 2019
2018 1.08K +926 +592% Jan 1, 2018 Dec 31, 2018
2017 157 -44.4 -22.1% Jan 1, 2017 Dec 31, 2017
2016 201 +1.01K Jan 1, 2016 Dec 31, 2016
2015 -812 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.